Fig. 3
From: High expression of p62/SQSTM1 predicts shorter survival for patients with pancreatic cancer
Immunohistochemical staining for p62, LC3, and NRF2 in whole pancreatic tumor tissue sections. Representative areas of pancreatic cancers stained for p62, LC3, and NRF2 and degree of staining scored as low or high. Negative controls were stained with matching isotype control antibodies. Scale bars, 100 μm (brown: positive antibody staining; blue: hematoxylin for nuclei staining)